B-Cell Chronic Lymphocytic Leukemia Treatment: Adoption of Drug Therapy, High Dose Chemotherapy Observed
Chronic lymphocytic leukemia, the most common form of adult leukemia, often arises from a malignant clone of B cells and has a characteristic phenotype. These introductory insights are according to the report titled, "Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Research Report 2019," which has been lately added to Market Research Hub's (MRH) ever-expanding repository. Patients who cannot put up with the side effects of strong chemotherapy are often treated with chlorambucil with a monoclonal antibody such as obinutuzumab (Gazyva). Meanwhile, durgs...
View full press release